TACE is required for fetal murine cardiac development and modeling

Developmental Biology

Volumn 261, Issue 2, 2003, Pages 371-380

  Shi, Wei ^a,b   Chen, Hui ^a   Sun, Jianping ^b   Buckley, Sue ^b   Zhao, Jingsong ^a   Anderson, Kathryn D ^b   Williams, Roberta G ^b   Warburton, David ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Cardiomyocyte; Heart development; TACE

Indexed keywords

CELL SURFACE PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; ENZYME ACTIVATION; FETUS; FETUS HEART; HEART DEVELOPMENT; HEART MUSCLE; HEART MUSCLE CELL; HEART VENTRICLE; MOUSE; MUTANT; NONHUMAN; NULL ALLELE; PATHOLOGY; PREGNANCY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGULATORY MECHANISM;

MURINAE;

EID: 0042887604     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0012-1606(03)00315-4     Document Type: Article

References (46)

1. Asakura M., Kitakaze M., Takashima S., Liao Y., Ishikura F., Yoshinaka T., Ohmoto H., Node K., Yoshino K., Ishiguro H., Asanuma H., Sanada S., Matsumura Y., Takeda H., Beppu S., Tada M., Hori M., Higashiyama S. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF metalloproteinase inhibitors as a new therapy . Nat. Med. 8:2002;35-40.
2. Black R.A. Tumor necrosis factor-alpha converting enzyme. Int. J. Biochem. Cell Biol. 34:2002;1-5.
3. Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Stack J.L., Wolfson M.F., Castner B.J., Stocking K.L., Reddy P., Srinivasan S., Nelson N., Boiani N., Schooley K.A., Gerhart M., Davis R., Fitzner J.N., Johnson R.S., Paxton R.J., March C.J., Cerretti D.P. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature. 385:1997;729-733.
4. Brannan C.I., Perkins A.S., Vogel K.S., Ratner N., Nordlund M.L., Reid S.W., Buchberg A.M., Jenkins N.A., Parada L.F., Copeland N.G. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev. 8:1994;1019-1029.
5. Brou C., Logeat F., Gupta N., Bessia C., Lebail O., Doedens J.R., Cumano A., Roux P., Black R.A., Israel A. A novel proteolytic cleavage involved in Notch signaling the role of the disintegrin-metalloprotease TACE . Mol. Cell. 5:2000;207-216.
6. Buxbaum J.D., Liu K.N., Luo Y., Stack J.L., Stocking K.L., Peschon J.J., Johnson R.S., Castner B.J., Cerretti D.P., Black R.A. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273:1998;27765-27767.
7. Charron J., Malynn B.A., Fisher P., Stewart V., Jeannotte L., Goff S.P., Robertson E.J., Alt F.W. Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene. Genes Dev. 6:1992;2248-2257.
8. Chen Z., Friedrich G.A., Soriano P. Transcriptional enhancer factor 1 disruption by a retroviral gene trap leads to heart defects and embryonic lethality in mice. Genes Dev. 8:1994;2293-2301.
9. Chin T.K., Perloff J.K., Williams R.G., Jue K., Mohrmann R. Isolated noncompaction of left ventricular myocardium. A study of eight cases. Circulation. 82:1990;507-513.
10. Clerk A., Sugden P.H. Activation of protein kinase cascades in the heart by hypertrophic G protein-coupled receptor agonists. Am. J. Cardiol. 83:1999;64H-69H.
11. Crackower M.A., Oudit G.Y., Kozieradzki I., Sarao R., Sun H., Sasaki T., Hirsch E., Suzuki A., Shioi T., Irie-Sasaki J., Sah R., Cheng H.Y., Rybin V.O., Lembo G., Fratta L., Oliveira-dos-Santos A.J., Benovic J.L., Kahn C.R., Izumo S., Steinberg S.F., Wymann M.P., Backx P.H., Penninger J.M. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell. 110:2002;737-749.
12. Crone S.A., Zhao Y.Y., Fan L., Gu Y., Minamisawa S., Liu Y., Peterson K.L., Chen J., Kahn R., Condorelli G., Ross J. Jr., Chien K.R., Lee K.F. ErbB2 is essential in the prevention of dilated cardiomyopathy. Nat. Med. 8:2002;459-465.
13. Gassmann M., Casagranda F., Orioli D., Simon H., Lai C., Klein R., Lemke G. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature. 378:1995;390-394.
14. Iwamoto R., Yamazaki S., Asakura M., Takashima S., Hasuwa H., Miyado K., Adachi S., Kitakaze M., Hashimoto K., Raab G., Nanba D., Higashiyama S., Hori M., Klagsbrun M., Mekada E. Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc. Natl. Acad. Sci. USA. 100:2003;3221-3226.
15. Jaber M., Koch W.J., Rockman H., Smith B., Bond R.A., Sulik K.K., Ross J. Jr., Lefkowitz R.J., Caron M.G., Giros B. Essential role of beta adrenergic receptor kinase 1 in cardiac development and function. Proc. Natl. Acad. Sci. USA. 93:1996;12974-12979.
16. Kheradmand F., Werb Z. Shedding light on sheddases role in growth and development . Bioessays. 24:2002;8-12.
17. Killar L., White J., Black R., Peschon J. Adamalysins. A family of metzincins including TNF-alpha converting enzyme (TACE). Ann. N. Y. Acad. Sci. 878:1999;442-452.
18. Luetteke N.C., Qiu T.H., Peiffer R.L., Oliver P., Smithies O., Lee D.C. TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell. 73:1993;263-278.
19. Lum L., Wong B.R., Josien R., Becherer J.D., Erdjument-Bromage H., Schlondorff J., Tempst P., Choi Y., Blobel C.P. Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J. Biol. Chem. 274:1999;13613-13618.
20. MacLellan W.R., Schneider M.D. Genetic dissection of cardiac growth control pathways. Annu. Rev. Physiol. 62:2000;289-319.
21. Manner J., Perez-Pomares J.M., Macias D., Munoz-Chapuli R. The origin, formation and developmental significance of the epicardium a review . Cells Tissues Organs. 169:2001;89-103.
22. Marino M.W., Dunn A., Grail D., Inglese M., Noguchi Y., Richards E., Jungbluth A., Wada H., Moore M., Williamson B., Basu S., Old L.J. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA. 94:1997;8093-8098.
23. Merlos-Suarez A., Ruiz-Paz S., Baselga J., Arribas J. Metalloprotease-dependent protransforming growth factor-alpha ectodomain shedding in the absence of tumor necrosis factor-alpha-converting enzyme. J. Biol. Chem. 276:2001;48510-48517.
24. Meyer D., Birchmeier C. Multiple essential functions of neuregulin in development. Nature. 378:1995;386-390.
25. Moss M.L., Jin S.L., Milla M.E., Bickett D.M., Burkhart W., Carter H.L., Chen W.J., Clay W.C., Didsbury J.R., Hassler D., Hoffman C.R., Kost T.A., Lambert M.H., Leesnitzer M.A., McCauley P., McGeehan G., Mitchell J., Moyer M., Pahel G., Rocque W., Overton L.K., Schoenen F., Seaton T., Su J.L., Becherer J.D. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature. 385:1997;733-736.
26. Nemoto S., Sheng Z., Lin A. Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy. Mol. Cell. Biol. 18:1998;3518-3526.
27. Nicol R.L., Frey N., Pearson G., Cobb M., Richardson J., Olson E.N. Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J. 20:2001;2757-2767.
28. Olson E.N., Srivastava D. Molecular pathways controlling heart development. Science. 272:1996;671-676.
29. Ozcelik C., Erdmann B., Pilz B., Wettschureck N., Britsch S., Hubner N., Chien K.R., Birchmeier C., Garratt A.N. Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy. Proc. Natl. Acad. Sci. USA. 99:2002;8880-8885.
30. Pasparakis M., Alexopoulou L., Episkopou V., Kollias G. Immune and inflammatory responses in TNF alpha-deficient mice a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response . J. Exp. Med. 184:1996;1397-1411.
31. Peschon J.J., Slack J.L., Reddy P., Stocking K.L., Sunnarborg S.W., Lee D.C., Russell W.E., Castner B.J., Johnson R.S., Fitzner J.N., Boyce R.W., Nelson N., Kozlosky C.J., Wolfson M.F., Rauch C.T., Cerretti D.P., Paxton R.J., March C.J., Black R.A. An essential role for ectodomain shedding in mammalian development. Science. 282:1998;1281-1284.
32. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:2001;2003-2007.
33. Prenzel N., Zwick E., Daub H., Leserer M., Abraham R., Wallasch C., Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 402:1999;884-888.
34. Primakoff P., Myles D.G. The ADAM gene family surface proteins with adhesion and protease activity . Trends Genet. 16:2000;83-87.
35. Rio C., Buxbaum J.D., Peschon J.J., Corfas G. Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4. J. Biol. Chem. 275:2000;10379-10387.
36. Schmitt J.P., Kamisago M., Asahi M., Li G.H., Ahmad F., Mende U., Kranias E.G., MacLennan D.H., Seidman J.G., Seidman C.E. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science. 299:2003;1410-1413.
37. Shi W., Heisterkamp N., Groffen J., Zhao J., Warburton D., Kaartinen V. TGF-beta3-null mutation does not abrogate fetal lung maturation in vivo by glucocorticoids. Am. J. Physiol. 277:1999;L1205-L1213.
38. Shin C.H., Liu Z.P., Passier R., Zhang C.L., Wang D.Z., Harris T.M., Yamagishi H., Richardson J.A., Childs G., Olson E.N. Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell. 110:2002;725-735.
39. Shou W., Aghdasi B., Armstrong D.L., Guo Q., Bao S., Charng M.J., Mathews L.M., Schneider M.D., Hamilton S.L., Matzuk M.M. Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12. Nature. 391:1998;489-492.
40. Sucov H.M., Dyson E., Gumeringer C.L., Price J., Chien K.R., Evans R.M. RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev. 8:1994;1007-1018.
41. Sugden P.H., Clerk A. Cellular mechanisms of cardiac hypertrophy. J. Mol. Med. 76:1998;725-746.
42. Sunnarborg S.W., Hinkle C.L., Stevenson M., Russell W.E., Raska C.S., Peschon J.J., Castner B.J., Gerhart M.J., Paxton R.J., Black R.A., Lee D.C. Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J. Biol. Chem. 277:2002;12838-12845.
43. Wang Y., Huang S., Sah V.P., Ross J. Jr., Brown J.H., Han J., Chien K.R. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J. Biol. Chem. 273:1998;2161-2168.
44. Wang Y., Su B., Sah V.P., Brown J.H., Han J., Chien K.R. Cardiac hypertrophy induced by mitogen-activated protein kinase kinase 7, a specific activator for c-Jun NH2-terminal kinase in ventricular muscle cells. J. Biol. Chem. 273:1998;5423-5426.
45. Zhao J., Chen H., Peschon J.J., Shi W., Zhang Y., Frank S.J., Warburton D. Pulmonary hypoplasia in mice lacking tumor necrosis factor-alpha converting enzyme indicates an indispensable role for cell surface protein shedding during embryonic lung branching morphogenesis. Dev. Biol. 232:2001;204-218.
46. Zhao J., Shi W., Chen H., Warburton D. Smad7 and Smad6 differentially modulate transforming growth factor beta-induced inhibition of embryonic lung morphogenesis. J. Biol. Chem. 275:2000;23992-23997.